| |
| |
|
| Insider
Information: |
Flaherty Keith T. |
| Relationship: |
|
| City: |
Boulder |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Loxo Oncology, Inc. |
LOXO |
Director |
2019-02-15 |
0 |
|
0 |
Premium* |
|
|
Kinnate Biopharma Inc. |
KNTE |
|
2024-04-03 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNTE |
Kinnate Biopharma Inc. |
|
– • – |
2024-04-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(66,377) |
0 |
0 |
- |
|
| KNTE |
Kinnate Biopharma Inc. |
|
– • – |
2020-12-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
66,377 |
|
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2019-02-15 |
4 |
D |
$235.00 |
$2,287,020 |
D/D |
(9,732) |
0 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2018-06-07 |
4 |
S |
$169.85 |
$8,677,027 |
D/D |
(50,000) |
9,732 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2018-06-07 |
4 |
OE |
$1.18 |
$59,200 |
D/D |
50,000 |
59,732 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2017-11-20 |
4 |
AS |
$75.35 |
$550,921 |
D/D |
(7,250) |
9,732 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2017-08-21 |
4 |
AS |
$71.91 |
$523,883 |
D/D |
(7,250) |
16,982 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2017-05-22 |
4 |
AS |
$44.64 |
$326,936 |
D/D |
(7,250) |
24,232 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2017-02-21 |
4 |
AS |
$41.45 |
$300,517 |
D/D |
(7,250) |
31,482 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2016-12-19 |
4 |
AS |
$30.23 |
$219,168 |
D/D |
(7,250) |
38,732 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2016-09-07 |
4 |
AS |
$30.00 |
$435,000 |
D/D |
(14,500) |
45,982 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2016-08-11 |
4 |
AS |
$26.00 |
$389,967 |
D/D |
(15,000) |
60,482 |
0 |
- |
|
| LOXO |
Loxo Oncology, Inc. |
Director |
– • – |
2014-07-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
75,482 |
|
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
